Beurer GL43 mg/dL
31
100% within ±15 mg/dL (±0.83 mmol/L) and 98,9% within ±15% of the values obtained in the medi-
cal laboratory with glucose concentrations of at least 100 mg/dL (5.55 mmol/L).
You will find further details and information regarding blood glucose results and various technologies
in generally relevant specialist medical literature.
12. u
saGe
limits
for
specialist
personnel
from
the
healthcare
sector
1. If the patient shows the following symptoms, it may be the case that no correct values can be
displayed:
• Acute dehydration
• Acute hypotension (low blood pressure)
• Shock
• Hyperosmolar hyperglycaemic condition (with or without ketosis)
2. Lipaemic samples: cholesterol levels up to 500 mg/dL and triglycerid levels up to 1000 mg/dL do
not influence the results. Severely lipaemic blood samples were not tested with the Beurer GL43
blood glucose monitor; therefore, using the device with these samples is not recommended.
3. In the case of severely ill patients, blood glucose monitors for home use should not be used.
4. The influence of interfering substances on the measurements depends on the concentration in
the blood. The maximum concentrations of certain substances listed below do not significantly
influence the measurements.
Concentration
of tested substances
50-100 mg/dL
(2.8-5.6 mmol/L)
250-350 mg/dL
(13.9-19.4 mmol/L)
Acetaminophen
10 mg/dL
(0.66 mmol/L)
-1.2 mg/dL
(-0.07 mmol/L)
-0.18%
Ascorbinsäure
4 mg/dL
(0.23 mmol/L)
8.3 mg/dL
(0.46 mmol/L)
3.52%
Bilirubin
20 mg/dL
(0.34 mmol/L)
-0.1 mg/dL
(-0.01 mmol/L)
0.37%
Cholesterol
500 mg/dL
(12.93 mmol/L)
-0.0 mg/dL
(-0.00 mmol/L)
-0.05%
Creatinin
10 mg/dL
(0.88 mmol/L)
0.2 mg/dL
(0.01 mmol/L)
-0.28%
Dopamin
5 mg/dL
(0.33 mmol/L)
0.50 mg/dL
(0.03 mmol/L)
0.04%
Blood glucose
value
Influence
